Rovaldi Christopher has filed 3 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 60000 shares of Keros Therapeutics, Inc. ($KROS) on February 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2025 | Keros Therapeutics, Inc. | $KROS | Rovaldi Christopher | Chief Operating Officer | A | Common Stock | 60000 | $0.00 | 60,000.0000 | 37,437,652 | 9999.99% | 0.16% |
| Feb. 13, 2024 | Keros Therapeutics, Inc. | $KROS | Rovaldi Christopher | CHIEF OPERATING OFFICER | A | Employee Stock Option (right to buy) | 150000 | $0.00 | 150,000.0000 | 29,447,119 | 9999.99% | 0.51% |
| Feb. 16, 2023 | Keros Therapeutics, Inc. | $KROS | Rovaldi Christopher | Chief Operating Officer | A | Employee Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 25,241,030 | 9999.99% | 0.40% |